We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBRX icon
6826
Forte Biosciences
FBRX
$1.57B
$21K ﹤0.01%
104
+60
+136% +$13.6K
FLEU icon
6827
Franklin FTSE Eurozone ETF
FLEU
$74M
$21K ﹤0.01%
847
FTXR icon
6828
First Trust Nasdaq Transportation ETF
FTXR
$1.06B
$21K ﹤0.01%
854
-19
-2% -$456
TBHC
6829
DELISTED
The Brand House Collective
TBHC
$21K ﹤0.01%
17,255
+12,105
+235% +$16.2K
LMB icon
6830
Limbach Holdings
LMB
$581M
$21K ﹤0.01%
5,634
-586
-9% -$2.28K
LOOP icon
6831
Loop Industries
LOOP
$32.9M
$21K ﹤0.01%
2,115
SEGG
6832
Sports Entertainment Gaming Global Corp
SEGG
$8.25M
$21K ﹤0.01%
1
MNPR icon
6833
Monopar Therapeutics
MNPR
$799M
$21K ﹤0.01%
+258
New +$26.9K
MSC
6834
Studio City International Holdings
MSC
$349M
$21K ﹤0.01%
1,078
-191
-15% -$3.72K
MTR
6835
Mesa Royalty Trust
MTR
$5.33M
$21K ﹤0.01%
3,060
+2,435
+390% +$18.1K
PH icon
6836
PUT
Parker-Hannifin
PH
$135B
$21K ﹤0.01%
+100
New +$19.4K
RDVT icon
6837
Red Violet
RDVT
$924M
$21K ﹤0.01%
1,159
+785
+210% +$12.7K
BLNE
6838
Beeline Holdings
BLNE
$33.2M
$21K ﹤0.01%
36
+23
+177% +$17.5K
VIRX
6839
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$21K ﹤0.01%
1,782
+928
+109% +$15.5K
MTBL
6840
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$21K ﹤0.01%
28,190
-23,753
-46% -$5.41K
PSMB
6841
DELISTED
Invesco Balanced Multi-Asset Allocation ETF
PSMB
$21K ﹤0.01%
+1,475
New +$21K
AMPE
6842
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$21K ﹤0.01%
118
-30
-20% -$3.88K
NFH
6843
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
$21K ﹤0.01%
+2,069
New +$21.1K
HMG
6844
DELISTED
HMG / Courtland Properties Inc
HMG
$21K ﹤0.01%
1,664
+264
+19% +$3.54K
BWL.A
6845
DELISTED
Bowl America Incorporated
BWL.A
$21K ﹤0.01%
1,381
-1,983
-59% -$30.4K
THCBU
6846
DELISTED
Tuscan Holdings Corp. Unit
THCBU
$21K ﹤0.01%
2,000
-600
-23% -$6.31K
SSPKU
6847
DELISTED
Silver Spike Acquisition Corp. Units
SSPKU
$21K ﹤0.01%
2,100
-283
-12% -$2.87K
UCI
6848
DELISTED
E-TRACS UBS Bloomberg CMCI ETN
UCI
$21K ﹤0.01%
1,437
-257
-15% -$3.7K
CFFAU
6849
DELISTED
CF Finance Acquisition Corp. Unit
CFFAU
$21K ﹤0.01%
1,970
+90
+5% +$966
FTACU
6850
DELISTED
FinTech Acquisition Corp. III Unit
FTACU
$21K ﹤0.01%
1,967
-302
-13% -$3.23K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.